Results 181 to 190 of about 111,213 (213)

Strategic resource allocation: an agent-based model of ambidextrous strategies in the pharmaceutical industry. [PDF]

Cost Eff Resour Alloc
Pourzia S, Hajipour B.
europepmc   +1 more source

The power of many: when genetics met yeasts and high‐throughput

Biological Reviews, EarlyView.
ABSTRACT In recent years, complex technological capabilities have evolved, driven by the need to solve complex and integrative biological questions through global analyses. New equipment allows the scaling up and automation of processes which previously were carried out on a very limited scale.
Víctor A. Tallada, Víctor Carranco
wiley   +1 more source

Platform Business Model Innovation for Sustainability: A Framework for Industry 5.0 Integration

Business Strategy and the Environment, EarlyView.
ABSTRACT A comprehensive framework is developed for adopting Platform Business Model Innovation (PBMI) to enhance sustainable performance in the Industry 5.0 (I5.0) era. While PBMI plays a growing role in corporate transformation, tensions persist between profit‐driven objectives and broader sustainability imperatives.
Mohamed Ashmel Mohamed Hashim, Issam Tlemsani, Ansarullah Tantry, Songdi Li   +3 more
wiley   +1 more source

Rapid Analysis of Sports Prohibited Substances in Black Market Pharmaceutical Products Using Atmospheric Solids Analysis Probe-Mass Spectrometry. [PDF]

Anal Sci Adv
Henderson A, Krug O, Sage A, Douce D, Campbell SJ, Moncur J, Thevis M, Heaney LM.   +7 more
europepmc   +1 more source

Sailing From Penalties to Accountability: Business Strategies and Governance for Firms to Innovate After Environmental Misconduct

Business Strategy and the Environment, EarlyView.
ABSTRACT Firms' continuous pursuit of making a profit in the competitive market may ignore the actions related to environmental responsibilities. This set of actions for financial gains constitutes environmental misconduct, which not only harms ecosystems and communities but also brings reputational damage. Negative press and social media amplification
Ashutosh Singh, Salwa Saleh Almasabi, Ajay Kumar Patel, Priyanka Malik   +3 more
wiley   +1 more source

Promoting Sustainable Prescribing-A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees. [PDF]

Pharmacol Res Perspect
Ericsson B, Lindahl U, Villén J, Nekoro M, Ramström H, Wettermark B.   +5 more
europepmc   +1 more source

ESG Performance, Debt Financing, and R&D Output: Evidence From the Healthcare Sector

Business Strategy and the Environment, EarlyView.
ABSTRACT Amid growing calls for sustainability in the healthcare sector, this study examines how and under what conditions environmental, social, and governance (ESG) performance influences research and development (R&D) output. Although existing studies suggest that ESG performance enhances R&D output, the financial mechanisms that enable or constrain
Sarmad Ali, Oriana Ciani, Simone Ghislandi   +2 more
wiley   +1 more source

The launch and diffusion of new patented medicines by therapeutic value. [PDF]

Health Aff Sch
Zhang W, Guh DP, Tam ACT, Grootendorst P, Hollis A, Anis AH.   +5 more
europepmc   +1 more source

Digital transformation, green finance, and pharmaceutical affordability in China: a health economics perspective. [PDF]

Front Public Health
Huang J, Zhang X.
europepmc   +1 more source

Access in all areas? A round-up of developments in market access and health technology assessment: part 13. [PDF]

J Comp Eff Res
Ramagopalan SV, Pannelay AJ.
europepmc   +1 more source